Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3912]

FRACTION-RCC: Evaluating nivolumab plus ipilimumab in patients with treatment...

Prof Scott Tykodi - University of Washington, Seattle, USA

$FRACTION-RCC: Evaluating nivolumab plus ipilimumab in patients with treatment-refractory advanced renal cell carcinoma ( Prof Scott Tykodi - University of Washington, Seattle, USA )$

CAPIRI versus irinotecan for the treatment of advanced gall bladder cancer...

Dr Anant Ramaswamy - Tata Memorial Hospital, Mumbai, India

CAPIRI versus irinotecan for the treatment of advanced gall bladder cancer patients progressing on first-line chemotherapy ( Dr Anant Ramaswamy - Tata Memorial Hospital, Mumbai, India )

DELIVER: Investigating the efficacy of nivolumab treatment in gastric cancer

Prof Yu Sunakawa - St. Marianna University School of Medicine, Kawasaki, Japan

DELIVER: Investigating the efficacy of nivolumab treatment in gastric cancer ( Prof Yu Sunakawa - St. Marianna University School of Medicine, Kawasaki, Japan )

HERO: Relugolix versus leuprolide acetate for advanced prostate cancer

Dr Neal Shore - Carolina Urologic Research Center, South Carolina, USA

HERO: Relugolix versus leuprolide acetate for advanced prostate cancer ( Dr Neal Shore - Carolina Urologic Research Center, South Carolina, USA )

Evaluating the impact of daratumumab for the treatment of multiple myeloma...

Dr Luciano Costa - O'Neal Comprehensive Cancer Center at UAB, Birmingham, USA

Evaluating the impact of daratumumab for the treatment of multiple myeloma according to cytogenetic risk ( Dr Luciano Costa - O'Neal Comprehensive Cancer Center at UAB, Birmingham, USA )

MASTER trial updates: Dara-KRd induction, autologous transplantation and MRD...

Dr Luciano Costa - O'Neal Comprehensive Cancer Center at UAB, Birmingham, USA

MASTER trial updates: Dara-KRd induction, autologous transplantation and MRD response-adapted consolidation in NDMM ( Dr Luciano Costa - O'Neal Comprehensive Cancer Center at UAB, Birmingham, USA )

UKALL2011: Treatment with a tyrosine kinase inhibitor improves outcomes for...

Prof Anthony Moorman - Newcastle University, Newcastle upon Tyne, UK

UKALL2011: Treatment with a tyrosine kinase inhibitor improves outcomes for patients with acute lymphoblastic leukaemia and an ABL-class fusion ( Prof Anthony Moorman - Newcastle University, Newcastle upon Tyne, UK )

Phase I/II results: First-line NALIRIFOX in patients with pancreatic ductal...

Dr Zev Wainberg - Ronald Reagan UCLA Medical Center, Los Angeles, USA

Phase I/II results: First-line NALIRIFOX in patients with pancreatic ductal adenocarcinoma ( Dr Zev Wainberg - Ronald Reagan UCLA Medical Center, Los Angeles, USA )

Long-term disease control in multiple myeloma by in-class transitioning: A...

Dr Robert Rifkin - Rocky Mountain Cancer Centers, Denver, USA

Long-term disease control in multiple myeloma by in-class transitioning: A community-based study ( Dr Robert Rifkin - Rocky Mountain Cancer Centers, Denver, USA )

Venetoclax plus navitoclax in R/R ALL and lymphoblastic lymphoma

Dr Elias Jabbour - MD Anderson Cancer Center, Houston, USA

Venetoclax plus navitoclax in R/R ALL and lymphoblastic lymphoma ( Dr Elias Jabbour - MD Anderson Cancer Center, Houston, USA )

Treating acute lymphoblastic leukaemia in the era of COVID-19

Dr Elias Jabbour - MD Anderson Cancer Center, Houston, USA

Treating acute lymphoblastic leukaemia in the era of COVID-19 ( Dr Elias Jabbour - MD Anderson Cancer Center, Houston, USA )

COVID-19 and impact on gynecologic oncology practice in India: Results of a...

Dr Anupama Rajanbabu - Amrita Institute of Medical Sciences, Kochi, India

COVID-19 and impact on gynecologic oncology practice in India: Results of a nationwide survey ( Dr Anupama Rajanbabu - Amrita Institute of Medical Sciences, Kochi, India )

More from ecancer